A new strategy for developing meningitis vaccines

Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain. Children, elderly patients and immunocompromised patients are at a higher risk for the development of severe bacterial meningitis.

Recently, researchers at the University of Adelaide in Australia sought to identify new vaccine targets in , which is the most common cause of in the world. Led by Dr. Abiodun Ogunniyi, the research team developed a new method of screening for bacterial genes that are expressed during meningitis in brain tissue.

Using a mouse model system, the researchers examined mice infected with two different strains of S. pneumoniae. They identified a protein known as glycerophosphate oxidase, and showed that this protein was critical for the progression of bacteria from blood to brain in mice. They went on to show that a vaccine against glycerophosphate oxidase protected mice from . Their results not only suggest a new strategy for immunizing against Streptococcus pneumoniae, but also provide a blueprint for discovering additional genes from other pathogens contribute to meningitis.


Explore further

Flu helps spread pneumonia

Citation: A new strategy for developing meningitis vaccines (2012, May 24) retrieved 15 September 2019 from https://medicalxpress.com/news/2012-05-strategy-meningitis-vaccines.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more